You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 17, 2025

Drug Price Trends for CHILD ALLERGY RELIEF


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for CHILD ALLERGY RELIEF

Average Pharmacy Cost for CHILD ALLERGY RELIEF

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CHILD ALLERGY RELIEF 1 MG/ML 69230-0316-11 0.03452 ML 2025-01-22
CHILD ALLERGY RELIEF 5 MG/5 ML 70000-0473-01 0.03906 ML 2025-01-22
CHILD ALLERGY RELIEF 1 MG/ML 69230-0316-11 0.03525 ML 2024-12-18
CHILD ALLERGY RELIEF 5 MG/5 ML 70000-0473-01 0.03842 ML 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Children's Allergy Relief Medications

Introduction to Children's Allergy Relief Market

The market for children's allergy relief medications is experiencing significant growth, driven by increasing prevalence of allergies among children and advancements in diagnostic and therapeutic technologies. Here’s a comprehensive analysis of the market, including its current state, growth projections, and key factors influencing its development.

Prevalence of Pediatric Allergies

Pediatric allergies, including seasonal allergies, eczema, and food allergies, are on the rise. According to the CDC, in 2021, 27.2% of children were diagnosed with at least one of these main allergic conditions, with seasonal allergies affecting 18.9%, eczema affecting 10.8%, and food allergies affecting 5.8% of children[1].

Market Size and Growth Projections

The global pediatric allergy diagnostics market, closely related to the therapeutics market, was estimated at USD 2.44 billion in 2023 and is projected to grow at a CAGR of 10.1% from 2024 to 2030, reaching USD 4.68 billion by 2030[1].

The broader allergy therapeutics market, which includes treatments for both adults and children, was valued at USD 23.10 billion in 2023 and is expected to reach USD 36.47 billion by 2030, growing at a CAGR of 6.7% from 2024 to 2030[3].

Regional Analysis

North America

North America dominates the pediatric allergy diagnostics market, accounting for 36.44% of the revenue share in 2023. This is due to the rising incidence of allergies, supportive government initiatives, increased awareness, early diagnosis, and advancements in diagnostic technologies[1].

Asia and Latin America

The pediatric allergy diagnostics market in Asia, particularly in China, is growing rapidly due to increasing urbanization and environmental changes that contribute to higher allergy rates. In Latin America, government support and awareness programs are driving market growth[1].

Key Products in the Market

Children's ZYRTEC®

Children's ZYRTEC® is a prominent brand offering various allergy relief products for kids. These include liquid syrup and chewable tablets, both containing cetirizine HCl, an effective antihistamine. The liquid syrup provides 24-hour relief for symptoms such as runny nose, sneezing, and itchy nose and throat, and is suitable for children aged 2 and up[2][5].

Factors Driving Market Growth

Increasing Prevalence of Allergies

The rising incidence of allergic disorders, including allergic rhinitis, asthma, food allergies, and atopic dermatitis, is a primary driver of the market. Environmental factors, genetics, urbanization, and lifestyle changes are contributing to this increase[4].

Advancements in Diagnostic and Therapeutic Technologies

Advancements in diagnostic technologies and the development of personalized medical strategies are improving treatment effectiveness and patient outcomes. This includes the use of antihistamines, decongestants, corticosteroids, immunotherapy, and biologics[3].

Government Initiatives and Healthcare Infrastructure

Favorable government policies and investments in healthcare infrastructure are supporting the growth of the market. In regions like North America, advanced healthcare systems with well-established medical facilities are driving the demand for effective allergy therapeutics[1][4].

Economic Impact

The economic burden of allergies is significant. For instance, the annual cost of nasal allergies in the United States ranges between USD 3.0 and USD 4.0 billion, highlighting the urgent need for effective diagnostics and treatments[1].

Price Projections

Given the growing demand and advancements in the field, prices for children's allergy relief medications are likely to remain competitive while potentially increasing slightly due to the rising costs of research and development.

  • Short-Term Projections: Prices are expected to stabilize or see a minor increase in the short term, driven by market competition and the availability of generic alternatives.
  • Long-Term Projections: As new technologies and treatments emerge, there could be a moderate increase in prices to reflect the value of these advancements. However, this will be balanced by the increasing market size and competition.

Key Takeaways

  • The pediatric allergy diagnostics and therapeutics market is growing rapidly due to increasing allergy prevalence and advancements in diagnostic and therapeutic technologies.
  • North America dominates the market, but Asia and Latin America are experiencing significant growth.
  • Products like Children's ZYRTEC® are popular due to their effectiveness and convenience.
  • Government initiatives and healthcare infrastructure play a crucial role in market growth.
  • The economic burden of allergies underscores the need for effective diagnostics and treatments.

FAQs

1. What is the current size of the global pediatric allergy diagnostics market? The global pediatric allergy diagnostics market was estimated at USD 2.44 billion in 2023[1].

2. What is the projected growth rate of the pediatric allergy diagnostics market? The market is projected to grow at a CAGR of 10.1% from 2024 to 2030[1].

3. Which region dominates the pediatric allergy diagnostics market? North America dominates the market, accounting for 36.44% of the revenue share in 2023[1].

4. What are some common symptoms relieved by children's allergy medications? Common symptoms include runny nose, sneezing, itchy eyes, and itchy nose and throat[2][5].

5. What factors are driving the growth of the allergy therapeutics market? Factors include increasing prevalence of allergies, advancements in diagnostic and therapeutic technologies, and favorable government initiatives and healthcare infrastructure[1][3][4].

Sources

  1. Grand View Research - Pediatric Allergy Diagnostics Market Size, Share Report 2030
  2. ZYRTEC - Children's ZYRTEC® Allergy Relief Syrup with Cetirizine HCl
  3. Next Market Insights - Allergy Treatment Market Value Analysis & Forecast | 2024-2030
  4. GMI Insights - Allergy Therapeutics Market Size & Share Report, 2032
  5. ZYRTEC - Children's ZYRTEC® Chewable Allergy Medicine for Kids 2+

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.